Ananda talks about development of the nOPV2 vaccine its pathway to rollout, and field performance
While tremendous progress has been made in the fight against polio, wild poliovirus remains endemic to two countries and the threat of cVDPV outbreaks continues to loom.
Three polio survivors from Mozambique, Congo and Ethiopia share their experiences of living with the effects of disease, and their hope for a polio-free world.
Learn how the type 2 novel oral polio vaccine (nOPV2) is being rolled out across Africa to help more sustainably address outbreaks of a non-wild form of polio, cVDPV2, and protect children across the continent.
Despite success against wild polio in the African region, outbreaks of the non-wild form of polio, cVDPV2, continue. With continued country commitment to eradication, a future where no child in Africa is paralysed by the virus is possible.
Launch of the Polio Eradication Strategic Plan 2022-2026
We talk to Dr Wadood about the impact of COVID-19 on the global polio eradication effort, and how the polio infrastructure is supporting COVID response.
Dr. Hamid Jafari, Director of Polio Eradication for the WHO Eastern Mediterranean Region, speaks to us about the actions the programme is taking to turn the tide against the poliovirus in Afghanistan and elsewhere in the region.
Yared G. Yehualashet, Programme Manager for Polio Eradication at WHO Nigeria, speaks to us about the on-ground realities of the polio programme in Nigeria: partners, innovations, challenges, potential wild poliovirus certification on the horizon and more.
In Niger, a critical mass of religious leaders is helping to turn the tide against vaccine refusals. Support from traditional and religious leaders is bringing an attitudinal shift, building community acceptance and increased vaccination coverage.
To reach every last child, health workers sometimes travel on motorcycles and walk for hours to deliver the all-important life-saving vaccines. On the frontlines of the polio programme, health workers protect millions of children.
Polioviruses will be kept after eradication in a limited number of laboratories and vaccine manufacturing facilities worldwide. Containment of these viruses will be critical to maintaining a polio-free world.
Ticky Esoh Ebongue, Business Analysist for Polio Eradication at WHO in Geneva, speaks to us about the importance of transparent and accountable financial management, which helps both donors and countries in their strategic planning.
An animation explaining the relations between gender and polio eradication
Gender Analyst Sini Ramo talks about the relations between gender and polio eradication